Further innovation, like the NovaSeq, continued to push down these costs, and Illumina expects its new NovaSeq X Series to enable the $100 genome, which could greatly increase the accessibility of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback